These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3377633)

  • 1. [Diagnostic value of the dexamethasone suppression test in 65 cases of affective disorders according to DSM-III].
    Conde López V; Cuesta Zorita MJ
    Arch Neurobiol (Madr); 1988; 51(1):17-24. PubMed ID: 3377633
    [No Abstract]   [Full Text] [Related]  

  • 2. The dexamethasone suppression test: some limitations in the general hospital setting.
    Baron DA; Shea S; White K
    J Am Osteopath Assoc; 1984 Mar; 83(7):505-8. PubMed ID: 6706716
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experience with the diagnostic value with the dexamethasone suppression test in 100 cases of affective and non-affective mental disorders].
    Conde López V; Cuesta Zorita MJ
    Arch Neurobiol (Madr); 1987; 50(4):221-36. PubMed ID: 3662736
    [No Abstract]   [Full Text] [Related]  

  • 4. The dexamethasone suppression test: interaction of diagnosis, sex, and age in psychiatric inpatients.
    Nelson WH; Khan A; Orr WW; Tamragouri RN
    Biol Psychiatry; 1984 Sep; 19(9):1293-304. PubMed ID: 6498252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of the dexamethasone suppression test].
    Nishimon K; Sora I; Sato M; Otsuki S
    Seishin Shinkeigaku Zasshi; 1983; 85(11):821-3. PubMed ID: 6677919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dexamethasone suppression test as a marker of the course of affective disorders].
    Bousoño García MV; Bobes García J; Fernández Domínguez JM; García Prieto A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(1):13-8. PubMed ID: 3716903
    [No Abstract]   [Full Text] [Related]  

  • 7. The DST in psychotic depression: diagnostic and pathophysiologic implications.
    Schatzberg AF; Rothschild AJ; Bond TC; Cole JO
    Psychopharmacol Bull; 1984; 20(3):362-4. PubMed ID: 6473631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic evaluation of the dexamethasone suppression test in affective and dementia disorders in hospitalized elderly patients].
    Conde López V; Cuesta Zorita MJ; de Dios Francos A
    Arch Neurobiol (Madr); 1988; 51(3):117-28. PubMed ID: 3219014
    [No Abstract]   [Full Text] [Related]  

  • 9. [Usefulness of the dexamethasone suppression test in the diagnosis of affective disorders].
    Hanada K; Takahashi S
    Seishin Shinkeigaku Zasshi; 1983; 85(11):819-21. PubMed ID: 6677918
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
    Baxter L; Edell W; Gerner R; Fairbanks L; Gwirtsman H
    J Clin Psychiatry; 1984 Apr; 45(4):150-3. PubMed ID: 6715286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to dexamethasone in affective disorder outpatients.
    Steardo L; Cardone G; Casiello M; Sorge F; Muscettola G
    Acta Psychiatr Belg; 1984; 84(3):218-27. PubMed ID: 6485840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the dexamethasone suppression test using DSM-III criteria on an inpatient psychiatric unit.
    Evans DL; Nemeroff CB
    Biol Psychiatry; 1983 Apr; 18(4):505-11. PubMed ID: 6860725
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dexamethasone suppression in the depressed patient. Reflections apropos of an experience].
    Jonas C; Etienne T; Valat C
    Encephale; 1983; 9(2):111-22. PubMed ID: 6641613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective disorders: biological aspects.
    Ban TA
    Acta Neurol (Napoli); 1985 Apr; 7(2):129-34. PubMed ID: 2409751
    [No Abstract]   [Full Text] [Related]  

  • 15. Considerations on the ICD-11 classification of psychotic depression.
    Ostergaard SD; Rothschild AJ; Uggerby P; Munk-Jørgensen P; Bech P; Mors O
    Psychother Psychosom; 2012; 81(3):135-44. PubMed ID: 22398817
    [No Abstract]   [Full Text] [Related]  

  • 16. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 17. The dexamethasone suppression test and cerebral blood flow in primary major depression.
    Charles G; Uytdenhoef P; Portelange P; Wilmotte J; Mendlewicz J; Jacquy J
    Biol Psychiatry; 1983 Nov; 18(11):1336-8. PubMed ID: 6652166
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.